ouabain has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mest, HJ; Riedel, A; Schneider, S | 1 |
| Greenberg, SS; Summer, WR; Wang, Y; Xie, J | 1 |
| Leung, SW; Man, RY; Quan, A; Teoh, H | 1 |
| Forman, A; Glavind-Kristensen, M; Petersen, OB | 1 |
| Campbell, WB; Hillard, CJ; Kurian, J; Li, P; Pratt, PF | 1 |
| Martin, W; McNeish, AJ; Wilson, WS | 1 |
6 other study(ies) available for ouabain and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
The effect of substances influencing the arachidonic acid cascade on experimental cardiac arrhythmias.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Anti-Arrhythmia Agents; Arachidonic Acids; Arrhythmias, Cardiac; Epoprostenol; Guinea Pigs; Heart; Iloprost; Ouabain; Prostaglandin Endoperoxides, Synthetic; Reference Values; Sulfonamides | 1988 |
Ouabain enhances basal release of nitric oxide from carotid artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arginine; Bradykinin; Calcium; Carotid Arteries; In Vitro Techniques; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Ouabain; Prostaglandin Endoperoxides, Synthetic; Sodium-Potassium-Exchanging ATPase; Swine; Vasodilation | 1993 |
Endothelial dysfunction exacerbates the impairment of relaxation by lysophosphatidylcholine in porcine coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Indomethacin; Lysophosphatidylcholines; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Ouabain; Swine; Vasoconstrictor Agents | 1997 |
Effects of ouabain on the isolated human uteroplacental vasculature.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arteries; Blood Flow Velocity; Endothelium, Vascular; Female; Humans; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Ouabain; Placenta; Potassium; Pregnancy; Uterus | 1998 |
Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8,11,14-Eicosatrienoic Acid; Animals; Benzopyrans; Biological Factors; Bradykinin; Cardiotonic Agents; Cattle; Coronary Vessels; Dihydropyridines; Electrophysiology; Endothelium, Vascular; Membrane Potentials; Muscle, Smooth, Vascular; Nitroprusside; Ouabain; Peptides; Potassium; Potassium Channels; Tritium; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |
Dominant role of an endothelium-derived hyperpolarizing factor (EDHF)-like vasodilator in the ciliary vascular bed of the bovine isolated perfused eye.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Barium; Biological Factors; Blood Vessels; Bradykinin; Cattle; Charybdotoxin; Ciliary Body; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Eye; Flurbiprofen; Glyburide; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Ouabain; Oxadiazoles; Perfusion; Potassium; Potassium Channel Blockers; Pressure; Quinoxalines; Tetraethylammonium; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |